Cybin (HELP) Enterprise Value (2021 - 2025)
Cybin's (HELP) quarterly Enterprise Value came in at -$195.1 million in Q4 2025, down 100.0% YoY from $10339.2 billion in Q4 2024, and down 132.98% on a QoQ basis from -$83.8 million in Q3 2025.
Cybin (HELP) Enterprise Value (2021 - 2025) Analysis & Trends
Cybin (HELP) has 5 years of Enterprise Value data on file, last reported at -$195.1 million in Q4 2025.
- Quarterly Enterprise Value fell 100.0% year-over-year to -$195.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$195.1 million (down 100.0% YoY) and the FY2024 annual result came in at -$155.1 million, changed N/A from the prior year.
- Enterprise Value eased to -$195.1 million in Q4 2025, from -$83.8 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$7.0 million in Q2 2023 to a low of -$195.1 million in Q4 2025.
- A 5-year average of -$69.0 million and a median of -$50.4 million in 2021 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value soared 66.99% — and 2024, when it tumbled 1825.32%.
- Tracing HELP's Enterprise Value over 5 years: stood at -$50.2 million in 2021, then soared by 66.99% to -$16.6 million in 2022, then sank by 72.73% to -$28.6 million in 2023, then slumped by 240.58% to -$97.6 million in 2024, then slumped by 100.0% to -$195.1 million in 2025.
- The last three Enterprise Value figures came in at -$195.1 million (Q4 2025), -$83.8 million (Q3 2025), and -$97.6 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Cybin | 417.29 Mn | 417.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -195.13 Mn |
| Sep 30, 2025 | -83.75 Mn |
| Dec 31, 2024 | -97.56 Mn |
| Sep 30, 2024 | -113.12 Mn |
| Jun 30, 2024 | -134.00 Mn |
| Mar 31, 2024 | -155.10 Mn |
| Dec 31, 2023 | -28.65 Mn |
| Sep 30, 2023 | -13.51 Mn |
| Jun 30, 2023 | -6.96 Mn |
| Feb 28, 2023 | -32.01 Mn |
| Dec 31, 2022 | -16.58 Mn |
| Sep 30, 2022 | -22.95 Mn |
| Dec 31, 2021 | -50.24 Mn |
| Sep 30, 2021 | -59.52 Mn |
| Jun 30, 2021 | -44.60 Mn |
| Mar 31, 2021 | -50.59 Mn |